OpportunityTitle: Innovation for HIV Vaccine Discovery (R01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing innovative, high risk, high impact research to identify novel HIV vaccine concepts and targets. A further focus is to answer important scientific questions that will aid in the design and development of an effective immunogen that may provide long-term safe protection from either acquisition of, or ongoing infection by HIV. Thus, this FOA aims to support early discovery research by supporting the testing of novel hypotheses and approaches, and the potential for continued funding that is dependent upon achieving applicant-proposed and pre-award negotiated Go/No-Go criterion/criteria by the year-2 progress report.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;